• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆管癌患者人体微生物群的生态失调

Dysbiosis in the Human Microbiome of Cholangiocarcinoma.

作者信息

Rao Benchen, Ren Tong, Wang Xuemei, Wang Haiyu, Zou Yawen, Sun Ying, Liu Shanshuo, Ren Zhigang, Yu Zujiang

机构信息

Department of Infectious Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Gene Hospital of Henan Province, Precision Medicine Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

出版信息

Front Physiol. 2021 Nov 12;12:715536. doi: 10.3389/fphys.2021.715536. eCollection 2021.

DOI:10.3389/fphys.2021.715536
PMID:34867436
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8633309/
Abstract

Cholangiocarcinoma (CCA) is the most common malignant tumor of the biliary system with a very poor prognosis. The human microbiome, which is the sum of the genetic information of human microorganisms, plays an important role in regulating the digestion, absorption, immune response, and metabolism of the host. Increasing evidence indicates a close relationship between CCA and the human microbiome. Specific alterations occur in the human microbiome of patients with CCA. Therefore, in this review, we aimed to summarize the recent evidence on dysbiosis in the human microbiome of CCA. Then, we generalized the effect of on CCA. Additionally, the potential mechanism of human microbial dysbiosis promoted the progress of CCA, and its precancerous disease was also explored. Furthermore, the possibility of the human microbiome as a diagnostic and therapeutic target of CCA was discussed.

摘要

胆管癌(CCA)是胆道系统最常见的恶性肿瘤,预后极差。人类微生物组是人类微生物遗传信息的总和,在调节宿主的消化、吸收、免疫反应和代谢方面发挥着重要作用。越来越多的证据表明CCA与人类微生物组之间存在密切关系。CCA患者的人类微生物组会发生特定改变。因此,在本综述中,我们旨在总结近期关于CCA患者人类微生物组失调的证据。然后,我们归纳了其对CCA的影响。此外,还探讨了人类微生物失调促进CCA进展及其癌前疾病的潜在机制。此外,还讨论了人类微生物组作为CCA诊断和治疗靶点的可能性。

相似文献

1
Dysbiosis in the Human Microbiome of Cholangiocarcinoma.胆管癌患者人体微生物群的生态失调
Front Physiol. 2021 Nov 12;12:715536. doi: 10.3389/fphys.2021.715536. eCollection 2021.
2
New challenges in cholangiocarcinoma candidates for elective surgery: harnessing the microbiome dysbiosis.胆管癌择期手术候选者面临的新挑战:利用微生物失调。
Langenbecks Arch Surg. 2023 Mar 31;408(1):134. doi: 10.1007/s00423-023-02867-8.
3
Characterization of biliary microbiota dysbiosis in extrahepatic cholangiocarcinoma.肝外胆管癌胆道微生物群失调的特征。
PLoS One. 2021 Mar 9;16(3):e0247798. doi: 10.1371/journal.pone.0247798. eCollection 2021.
4
Helicobacter Species are Possible Risk Factors of Cholangiocarcinoma.幽门螺杆菌属是胆管癌的可能危险因素。
Asian Pac J Cancer Prev. 2016;17(1):37-44. doi: 10.7314/apjcp.2016.17.1.37.
5
[Microbiome and Biliary Tract Cancer].[微生物组与胆管癌]
Korean J Gastroenterol. 2024 Jan 25;83(1):1-5. doi: 10.4166/kjg.2023.135.
6
Profiling of Bile Microbiome Identifies District Microbial Population between Choledocholithiasis and Cholangiocarcinoma Patients.胆汁微生物组分析鉴定胆总管结石和胆管癌患者之间的区域微生物群。
Asian Pac J Cancer Prev. 2021 Jan 1;22(1):233-240. doi: 10.31557/APJCP.2021.22.1.233.
7
SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma.SOX17调节胆管细胞分化,并在胆管癌中作为一种肿瘤抑制因子发挥作用。
J Hepatol. 2017 Jul;67(1):72-83. doi: 10.1016/j.jhep.2017.02.017. Epub 2017 Feb 22.
8
The role of tumour microenvironment: a new vision for cholangiocarcinoma.肿瘤微环境的作用:胆管癌的新视角。
J Cell Mol Med. 2019 Jan;23(1):59-69. doi: 10.1111/jcmm.13953. Epub 2018 Nov 5.
9
The possible mechanisms of the human microbiome in allergic diseases.人类微生物群在过敏性疾病中的可能机制。
Eur Arch Otorhinolaryngol. 2017 Feb;274(2):617-626. doi: 10.1007/s00405-016-4058-6. Epub 2016 Apr 26.
10
Opisthorchiasis and the Microbiome.华支睾吸虫病与微生物组。
Adv Parasitol. 2018;102:1-23. doi: 10.1016/bs.apar.2018.07.001. Epub 2018 Aug 17.

引用本文的文献

1
Genomic Alterations and Microbiota Crosstalk in Hepatic Cancers: The Gut-Liver Axis in Tumorigenesis and Therapy.肝癌中的基因组改变与微生物群串扰:肿瘤发生与治疗中的肠-肝轴
Genes (Basel). 2025 Jul 30;16(8):920. doi: 10.3390/genes16080920.
2
Gut microbiome and serum metabolome alterations in osteosarcoma patients.骨肉瘤患者的肠道微生物群和血清代谢组改变
Front Microbiol. 2025 Jul 17;16:1616603. doi: 10.3389/fmicb.2025.1616603. eCollection 2025.
3
Dysbiosis of Bile Microbiota in Cholangiocarcinoma Patients: A Comparison with Benign Biliary Diseases.

本文引用的文献

1
Bile Microbiota in Patients with Pigment Common Bile Duct Stones.胆汁微生物群在色素性胆总管结石患者中的变化。
J Korean Med Sci. 2021 Apr 19;36(15):e94. doi: 10.3346/jkms.2021.36.e94.
2
Alterations in the human oral and gut microbiomes and lipidomics in COVID-19.新冠病毒感染患者口腔和肠道微生物组及脂质组的变化。
Gut. 2021 Jul;70(7):1253-1265. doi: 10.1136/gutjnl-2020-323826. Epub 2021 Mar 31.
3
Characterization of biliary microbiota dysbiosis in extrahepatic cholangiocarcinoma.肝外胆管癌胆道微生物群失调的特征。
胆管癌患者胆汁微生物群失调:与良性胆道疾病的比较
Int J Mol Sci. 2025 Feb 13;26(4):1577. doi: 10.3390/ijms26041577.
4
Microbiota and Radiotherapy: Unlocking the Potential for Improved Gastrointestinal Cancer Treatment.微生物群与放射治疗:挖掘改善胃肠道癌治疗效果的潜力
Biomedicines. 2025 Feb 19;13(2):526. doi: 10.3390/biomedicines13020526.
5
Exploring micronutrients and microbiome synergy: pioneering new paths in cancer therapy.探索微量营养素与微生物群的协同作用:开创癌症治疗新途径。
Front Immunol. 2024 Nov 29;15:1442788. doi: 10.3389/fimmu.2024.1442788. eCollection 2024.
6
Clonorchis sinensis infection induces pathological changes in feline bile duct epithelium and alters biliary microbiota composition.华支睾吸虫感染可导致猫胆管上皮发生病理性改变,并改变胆汁微生物群组成。
Parasite. 2024;31:53. doi: 10.1051/parasite/2024053. Epub 2024 Sep 6.
7
Metformin facilitates anti-PD-L1 efficacy through the regulation of intestinal microbiota.二甲双胍通过调节肠道微生物群促进抗PD-L1疗效。
Genes Immun. 2024 Feb;25(1):7-13. doi: 10.1038/s41435-023-00234-7. Epub 2023 Dec 13.
8
A Novel Bifidobacterium/Klebsiella Ratio in Characterization Analysis of the Gut and Bile Microbiota of CCA Patients.一种新型双歧杆菌/克雷伯氏菌比值在 CCA 患者肠道和胆汁微生物群特征分析中的应用。
Microb Ecol. 2023 Nov 30;87(1):5. doi: 10.1007/s00248-023-02318-3.
9
Oral Pathogenic Bacteria and the Oral-Gut-Liver Axis: A New Understanding of Chronic Liver Diseases.口腔致病细菌与口腔-肠道-肝脏轴:对慢性肝病的新认识
Diagnostics (Basel). 2023 Oct 26;13(21):3324. doi: 10.3390/diagnostics13213324.
10
Interplay between the Human Microbiome and Biliary Tract Cancer: Implications for Pathogenesis and Therapy.人类微生物组与胆管癌之间的相互作用:对发病机制和治疗的影响
Microorganisms. 2023 Oct 20;11(10):2598. doi: 10.3390/microorganisms11102598.
PLoS One. 2021 Mar 9;16(3):e0247798. doi: 10.1371/journal.pone.0247798. eCollection 2021.
4
Bacterial bile duct colonization in perihilar cholangiocarcinoma and its clinical significance.肝门部胆管癌中的细菌胆管定植及其临床意义。
Sci Rep. 2021 Feb 3;11(1):2926. doi: 10.1038/s41598-021-82378-y.
5
Human bile microbiota: A retrospective study focusing on age and gender.人类胆汁菌群:一项关注年龄和性别的回顾性研究。
J Infect Public Health. 2021 Feb;14(2):206-213. doi: 10.1016/j.jiph.2020.11.005. Epub 2021 Jan 22.
6
Altered Gut Microbial Metabolism of Essential Nutrients in Primary Sclerosing Cholangitis.原发性硬化性胆管炎中基本营养素的肠道微生物代谢改变。
Gastroenterology. 2021 Apr;160(5):1784-1798.e0. doi: 10.1053/j.gastro.2020.12.058. Epub 2020 Dec 31.
7
Gut Microbiome Directs Hepatocytes to Recruit MDSCs and Promote Cholangiocarcinoma.肠道微生物群指导肝细胞招募髓系抑制细胞并促进胆管癌。
Cancer Discov. 2021 May;11(5):1248-1267. doi: 10.1158/2159-8290.CD-20-0304. Epub 2020 Dec 15.
8
Cholangiocarcinoma 2020: the next horizon in mechanisms and management.胆管癌 2020:机制和管理的新前沿。
Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):557-588. doi: 10.1038/s41575-020-0310-z. Epub 2020 Jun 30.
9
Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders.肠道微生物组和肠道屏障对肝脏疾病的贡献。
Gastroenterology. 2020 Sep;159(3):849-863. doi: 10.1053/j.gastro.2020.04.077. Epub 2020 Jun 20.
10
The Role of the Intestine in the Pathogenesis of Primary Sclerosing Cholangitis: Evidence and Therapeutic Implications.肠道在原发性硬化性胆管炎发病机制中的作用:证据与治疗意义。
Hepatology. 2020 Sep;72(3):1127-1138. doi: 10.1002/hep.31311.